OTCBB:GTBP

Gt Biopharma Stock Forecast

etoro logo Buy GTBP
*Your capital is at risk
$0.687
-0.275 (-28.56%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of GTBP
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Volatile ride for GT Biopharma, Inc. stock price on Monday moving between $0.660 and $0.771
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 17, 2025

The GT Biopharma, Inc. stock price fell by -28.56% on the last day (Monday, 17th Nov 2025) from $0.96 to $0.687. During the last trading day the stock fluctuated 16.86% from a day low at $0.660 to a day high of $0.771. The price has risen in 6 of the last 10 days and is up by 10.3% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -8 million shares and in total, 2 million shares were bought and sold for approximately $1.33 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.49% during the next 3 months and, with a 90% probability hold a price between $0.222 and $0.645 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GTBP Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The GT Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.722 and $0.693. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 14, 2025, and so far it has fallen -28.56%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for GT Biopharma, Inc. stock

GT Biopharma, Inc. finds support from accumulated volume at $0.680 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.111 between high and low, or 16.86%. For the last week the stock has had daily average volatility of 20.12%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GTBP) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect GT Biopharma, Inc. to open at $0.706, and during the day (based on 14 day Average True Range), to move between $0.633 and $0.742, which gives a possible trading interval of +/-$0.109 (+/-17.29%) up or down from last closing price. If GT Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 17.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.680 (1.08%) than the resistance at $0.751 (9.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is GT Biopharma, Inc. stock A Buy?

GT Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.469 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.706 ( 2.75%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

GTBP Performance

Trading levels for GTBP

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.82 18.94%
R2 0.775 12.76%
R1 0.749 8.94%
Price 0.687
S1 0.664 -3.44%
S2 0.637 -7.26%
S3 0.595 -13.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.768 11.74%
R2 0.752 9.37%
R1 0.751 9.28%
Price 0.687
S1 0.680 -1.08%
S2 0.597 -13.12%
S3 0.580 -15.61%

FAQ

What is the symbol for GT Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for GT Biopharma, Inc. is GTBP and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell GT Biopharma, Inc. Stock?
GT Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy GT Biopharma, Inc. Stock?
GT Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GT Biopharma, Inc. Stock.

What's the current price of GT Biopharma, Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an GT Biopharma, Inc. (GTBP) share was $0.687.

What is the 52-week high and low for GT Biopharma, Inc. Stock?
The 52-week high for GT Biopharma, Inc. Stock is $4.10 and the 52-week low is $0.540.

What is the market capitalization of GT Biopharma, Inc. Stock?
As of the Nov 17, 2025, the market capitalization of GT Biopharma, Inc. is 2.444M.

When is the next earnings date for GT Biopharma, Inc.?
The upcoming earnings date for GT Biopharma, Inc. is Feb 20, 2026.
Click to get the best stock tips daily for free!
ABOUT GT BIOPHARMA, INC.
GT Biopharma
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE